choose content

Choose content

Enter keywords to create a newsletter
create account

Create account

Enter your registration information
set preferences

Set preferences

Set up your newsletter name, delivery and time zone preferences
Hint: Enter different keywords to generate new results.

Now you can:

  1. Search the news index.
  2. Browse more than 1 million newsletters by category.
  3. Use preset newsletters:
    • Cephalon Shares

Cephalon Shares Newsletter
  • Anti-epileptic Drugs for Pediatrics Market Assessment 2021-2026 | Mylan N.V., Cephalon, Inc., GlaxoSmithKline plc, Janssen Pharmaceuticals, Novartis AG 28 Feb 2021 22:30 GMT

    … marketing executives. The percentage splits, shares, and breakdowns of the product … Companies Data: Mylan N.V., Cephalon, Inc., GlaxoSmithKline plc, Janssen Pharmaceuticals … Top Companies Mylan N.V., Cephalon, Inc., GlaxoSmithKline plc, Janssen …

  • Pharma: Cephalon Inks Australian Investment 25 Oct 2010 14:10 GMT

    … .financialwire.net/ ) — Cephalon, Inc. (NASDAQ: CEPH) said … kinase inhibitor.   Separately, Cephalon also entered into option … outstanding shares at A$0.70 per share.   Cephalon … analyses. Pennsylvania-based Cephalon is a biopharmaceutical company …

  • Cephalon Prices 5 Million Common Shares, $435 Million Of Notes 21 May 2009 22:14 GMT

    … public offerings of five million shares of common stock, at … to maturity into cash and shares of the company&# … rate of approximately 14.4928 shares per $1,000 principal … p>Frazer, Pennsylvania-based Cephalon is a biopharmaceutical company focused …

  • MindMed Appoints Matt Wiley as Chief Commercial Officer 17 Mar 2025 11:27 GMT

    … work alongside a team that shares my dedication to improving … roles of increasing responsibility at Cephalon, Salix Pharmaceuticals, and MGI … aggregate of 350,000 common shares of the Company (the … be settled in MindMed common shares upon vesting, each with …

  • Global Transmucosal Drugs Market to Reach ~USD 28 Billion by 2032 | DelveInsight 19 Feb 2025 00:52 GMT

    … transmucosal drugs companies' market shares, challenges, transmucosal drugs market drivers … delivery devices companies, including 3M, Cephalon Inc., Biopharmaceutical, Antares Pharma, Teva …

  • 2024 M&A Annual Review 10 Feb 2025 20:26 GMT

    … have received for their shares had the deal closed, … several discussions with regulators, Cephalon halted development of another … the distributing parent retains shares of its controlled subsidiary … or the retention of shares in the controlled subsidiary …

  • M&A in 2024 and Trends for 2025 10 Jan 2025 19:54 GMT

    … have received for their shares had the deal closed, … several discussions with regulators, Cephalon halted development of another … the distributing parent retains shares of its controlled subsidiary … or the retention of shares in the controlled subsidiary …

  • Delaware Court of Chancery Weighs in on Earnout Provisions in Recent Cases 01 Nov 2024 03:43 GMT

    … acquired all of the outstanding shares of DDT.  Beckett Collectibles paid … Delaware earnout decision, Himawan v. Cephalon, Inc. (Himawan) (previously discussed in …

  • Multiple origins of dorsal ecdysial sutures in trilobites and their relatives 23 Aug 2024 22:47 GMT

    … et al., 2022). The cephalon, as an informative and … sutures in the trilobite cephalon have been central to … cephalic doublure from the dorsal cephalon (e.g. Stubblefield 1936 … phylogenetic results. Either Acanthomeridion shares the presence of facial …

  • Best-preserved trilobite fossils ever found shake up the scientific community 30 Jun 2024 23:59 GMT

    … of experience in studying trilobites, shares his awe-inspiring encounter with … , a three-part deal: a cephalon (that’s geek for the … El Albani, the lead author, shares his enthusiasm, saying, “As a …

Satisfied with the content?

Continue to create your account.